Showing results (491-500 of 1,401) with videos related to

Sort By:
Pageof 141
Pharmacology Research & Perspectives|August 15, 2017
Obeticholic acid, a selective farnesoid X receptor agonist, regulates bile acid homeostasis in sandwich-cultured human hepatocytesYuanyuan Zhang, Jonathan P Jackson, Robert L St Claire, et al.
Pharmacology Research & Perspectives|September 7, 2020
Comparing direct acting antivirals for hepatitis C using observational data - Why and how?Jim Young, Stanley Wong, Naveed Z Janjua, et al.
Pharmacology Research & Perspectives|October 22, 2020
Pharmacokinetics and biodistribution of a collagen-targeted peptide amphiphile for cardiovascular applicationsHussein A Kassam, Edward M Bahnson, Ana Cartaya, et al.
Pharmacology Research & Perspectives|October 22, 2020
Metabolite V, an epoxide species is a minor circulating metabolite in humans following a single oral dose of deflazacortRonald Kong, Jiyuan Ma, Brian Beers, et al.
Pharmacology Research & Perspectives|October 22, 2020
Quality of benzathine penicillin G: A multinational cross-sectional studyRobert M Hand, S M D K Ganga Senarathna, Madhu Page-Sharp, et al.
Pharmacology Research & Perspectives|June 23, 2022
Pharmacokinetics of extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide in adolescent and adult patients with asthmaPiotr Kuna, Joanna Jerzynska, Matteo Martini, et al.
Pharmacology Research & Perspectives|January 12, 2023
A humanized anti-cocaine mAb antagonizes the cardiovascular effects of cocaine in ratsSheryl E Koch, Jordan A Marckel, Jack Rubinstein, et al.
Pharmacology Research & Perspectives|December 26, 2022
The effect of Fingolimod on patients with moderate to severe COVID-19Soheil Teymouri, Siamak Pourbayram Kaleybar, Seyyed Sina Hejazian, et al.
Pharmacology Research & Perspectives|December 26, 2022
Xanthatin suppresses proliferation and tumorigenicity of glioma cells through autophagy inhibition via activation of the PI3K-Akt-mTOR pathwayHuaqing Chen, Tong Zhu, Xiaojie Huang, et al.
Pharmacology Research & Perspectives|December 30, 2022
MG53: A potential therapeutic target for kidney diseaseBen Ke, Wen Shen, Jianling Song, et al.
Pageof 141